Nemera Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 1,145

Employees

  • Latest Deal Type
  • Debt Refin.

  • Financing Rounds
  • 10

  • Investments
  • 4

Nemera General Information

Description

Manufacturer of plastic drug administration systems intended to build patient-centric and sustainable drug delivery devices that bring maximum value to customers, patients, and society. The company offers the production, designing, and selling of a broad range of complex medical devices and drug delivery devices, including inhalers, insulin pens, and pumps for the pharmaceutical, biotech, and generics industries, thereby helping maximize treatment efficacy.

Contact Information

Website
www.nemera.net
Formerly Known As
Rexam Healthcare Devices
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Medical Supplies
Other Industries
Drug Delivery
Corporate Office
  • 63 avenue Tony Garnier
  • 69007 Lyon
  • France
+33 04 00 00 00 00

Nemera Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nemera Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nemera‘s full profile, request access.

Request a free trial

Nemera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of plastic drug administration systems intended to build patient-centric and sustainable drug delivery devi
Medical Supplies
Lyon, France
1,145 As of 2023
00000
000000000 00 00000

000000

sequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum do
0000 00000000
Stuttgart, Germany
000 As of 0000
00000 0000-00-00
000000&0

000000

derit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur
0000000 00000000
Hellebaek, Denmark
0 As of 0000
00.000
000000 - 000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nemera Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Haselmeier Corporate Backed or Acquired Stuttgart, Germany 000 000000&0
Subcuject Venture Capital-Backed Hellebaek, Denmark 0 00.000 000000 - 000 00.000
LTS Lohmann Therapie-Systeme Private Equity-Backed Andernach, Germany 0000 0000000000
Owen Mumford Corporation Woodstock, United Kingdom 000 0000000000
ScPharmaceuticals Formerly VC-backed Burlington, MA 00 00000 000000000000 00000
You’re viewing 5 of 14 competitors. Get the full list »

Nemera Executive Team (3)

Name Title Board Seat
Marc Hämel Chief Executive Officer
Frédéric Brunet Chief Financial Officer
Sebastian Perrier Chief Operating Officer
To view Nemera’s complete executive team members history, request access »

Nemera Board Members (2)

Name Representing Role Since
0000 00000000 Nemera Chairman 000 0000
0é0000000 00000 Nemera Board Member 000 0000
To view Nemera’s complete board members history, request access »

Nemera Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nemera Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nemera‘s full profile, request access.

Request a free trial

Nemera Investments (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Hubly Surgical 01-May-2023 00000 00000 Surgical Devices
Milfra Soluções Milimétricas 17-Jun-2021 0000000000 Medical Supplies 0000 0ä00
Copernicus (Drug Delivery) 27-Oct-2020 0000000000 Drug Delivery 0000 0ä00
Insight Innovation Center 08-Aug-2019 Buyout/LBO Consulting Services (B2B) 0000 0ä00
To view Nemera’s complete investments history, request access »

Nemera Subsidiaries (2)

Company Name Industry Location Founded
Copernicus (Drug Delivery) Drug Delivery Szczecin, Poland 2004
Insight Innovation Center Consulting Services (B2B) Chicago, IL 0000
To view Nemera’s complete subsidiaries history, request access »

Nemera FAQs

  • When was Nemera founded?

    Nemera was founded in 2003.

  • Who is the CEO of Nemera?

    Marc Hämel is the CEO of Nemera.

  • Where is Nemera headquartered?

    Nemera is headquartered in Lyon, France.

  • What is the size of Nemera?

    Nemera has 1,145 total employees.

  • What industry is Nemera in?

    Nemera’s primary industry is Medical Supplies.

  • Is Nemera a private or public company?

    Nemera is a Private company.

  • What is Nemera’s current revenue?

    The current revenue for Nemera is 00000.

  • How much funding has Nemera raised over time?

    Nemera has raised $210M.

  • Who are Nemera’s investors?

    Astorg, ATP Private Equity Partners, Omnes Capital, and Montagu Private Equity have invested in Nemera.

  • Who are Nemera’s competitors?

    Haselmeier, Subcuject, LTS Lohmann Therapie-Systeme, Owen Mumford, and ScPharmaceuticals are some of the 14 competitors of Nemera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »